Skip to main content
. Author manuscript; available in PMC: 2015 Nov 2.
Published in final edited form as: Leuk Res. 2008 Jan 14;32(7):1005–1014. doi: 10.1016/j.leukres.2007.11.035

Table 2.

Hypermethylation of STAT inhibitors in non-leukemic hematologic malignancies patient samples

Gene Cancrer Type Number of cases Number of cases studied Percent Reference
SHP1 Multiple myeloma 27 34 79 48
SOCS1 Lymphoma 2 62 3 49
Multiple myeloma 23 35 63 49
38 51 75 50
0* 34 0 48
*

5′ promoter methylation (please see text for details)